Healthtech funding in H2 2010
European Healthtech startup funding raised during H2 2010.
In H2 2010, 21 European Healthtech companies closed 22 funding rounds and raised €140M in equity funding (excluding debt and grants), up 1.4% versus H2 2009. France led by capital raised, and Pitango Venture Capital was the most active investor. Data as of 6 Nov 2026.
Equity funding
€140M
+1.4% vs H2 2009 · excl. debt & grants
Funding rounds
22
+46.7% vs H2 2009
Companies
21
Top country
France
Rank among sectors
#4
5.9% of sector funding
Top-10 round share
89.1%
of disclosed capital
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, H2 2010 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jul | €48M | 6 |
| Aug | €4.4M | 2 |
| Sep | €27M | 7 |
| Oct | €8.1M | 5 |
| Nov | €35M | 1 |
| Dec | €17M | 1 |
Top countries
by € raisedHealthtech — top countries by capital, H2 2010 — interactive chart.
Data table
| Healthtech — top countries by capital, H2 2010 | |
|---|---|
| France | €59M |
| UK | €28M |
| Israel | €19M |
| Switzerland | €19M |
| Germany | €10M |
| Ireland | €2.9M |
| Denmark | €1.0M |
| Romania | €50k |
Stage mix
by € raisedHealthtech — stage mix, H2 2010 — interactive chart.
Data table
| Healthtech — stage mix, H2 2010 | |
|---|---|
| Series C | €55M |
| Series A | €29M |
| Series D+ | €22M |
| Early VC | €17M |
| Series B | €10M |
| Other | €5.8M |
| Seed | €394k |
Top deals
largest disclosed rounds in H2 2010| Company | Stage | Date | Amount |
|---|---|---|---|
| SuperSonic Imagine | Series C | Nov 2010 | €35M |
| Kymab | Series A | Jul 2010 | €25M |
| NovImmune | Series D+ | Dec 2010 | €17M |
| EarlySense | Series C | Jul 2010 | €11M |
| uTest_Vamsi | Series C | Sep 2010 | €10M |
| Protagen | Series B | Sep 2010 | €10M |
| EarlySense | Series D+ | Oct 2010 | €5.1M |
| Global Imaging Online | Early VC | Jul 2010 | €4.8M |
| Alyotech | Early VC | Jul 2010 | €4.0M |
| Camero;Inc | Early VC | Aug 2010 | €3.1M |
| WiThings | Series A | Sep 2010 | €3.0M |
| CommProve | Early VC | Oct 2010 | €2.9M |
| Anaconda Pharma | Other | Jul 2010 | €2.9M |
| Phagenesis | Other | Sep 2010 | €2.8M |
| InSphero | Series A | Aug 2010 | €1.3M |
Top investors
most active in H2 2010, by deal count- Pitango Venture Capital2 deals
- Amundi Private Equity Funds1 deals
- Aurinvest1 deals
- BNP Paribas1 deals
- BZ Bank1 deals
- CM-CIC Capital Prive1 deals
- Francois Derbaix1 deals
- High-Tech Gründerfonds (HTGF)1 deals
- Iris Capital1 deals
- JK&B Capital1 deals